Zaorsky NG - Search Results

1

Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?

Zaorsky NG, Studenski MT, Dicker AP, Gomella L, Den RB. Zaorsky NG, et al. Cancer Treat Rev. 2013 May;39(3):212-8. doi: 10.1016/j.ctrv.2012.10.003. Epub 2012 Dec 4. Cancer Treat Rev. 2013. PMID: 23218442 Review.

2

Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.

Shen X, Zaorsky NG, Mishra MV, Foley KA, Hyslop T, Hegarty S, Pizzi LT, Dicker AP, Showalter TN. Shen X, et al. Among authors: zaorsky ng. Future Oncol. 2012 Jan;8(1):37-54. doi: 10.2217/fon.11.131. Future Oncol. 2012. PMID: 22149034 Review.

3

The effect of ethnicity and sexual preference on prostate-cancer-related quality of life.

Kleinmann N, Zaorsky NG, Showalter TN, Gomella LG, Lallas CD, Trabulsi EJ. Kleinmann N, et al. Among authors: zaorsky ng. Nat Rev Urol. 2012 Apr 10;9(5):258-65. doi: 10.1038/nrurol.2012.56. Nat Rev Urol. 2012. PMID: 22487871 Review.

4

Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method.

Zaorsky NG, Li T, Devarajan K, Horwitz EM, Buyyounouski MK. Zaorsky NG, et al. Cancer. 2012 Nov 15;118(22):5535-43. doi: 10.1002/cncr.27597. Epub 2012 Apr 27. Cancer. 2012. PMID: 22544661 Free PMC article.

5

Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school.

Zaorsky NG, Malatesta TM, Den RB, Wuthrick E, Ahn PH, Werner-Wasik M, Shi W, Dicker AP, Anne PR, Bar-Ad V, Showalter TN. Zaorsky NG, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e465-9. doi: 10.1016/j.ijrobp.2012.01.058. Int J Radiat Oncol Biol Phys. 2012. PMID: 22704704

6

ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK.

Sun Y, Nowak KA, Zaorsky NG, Winchester CL, Dalal K, Giacalone NJ, Liu N, Werner-Wasik M, Wasik MA, Dicker AP, Lu B. Sun Y, et al. Among authors: zaorsky ng. Mol Cancer Ther. 2013 May;12(5):696-704. doi: 10.1158/1535-7163.MCT-12-0868. Epub 2013 Feb 26. Mol Cancer Ther. 2013. PMID: 23443800 Free PMC article.

7

Systematic review of hypofractionated radiation therapy for prostate cancer.

Zaorsky NG, Ohri N, Showalter TN, Dicker AP, Den RB. Zaorsky NG, et al. Cancer Treat Rev. 2013 Nov;39(7):728-36. doi: 10.1016/j.ctrv.2013.01.008. Epub 2013 Mar 1. Cancer Treat Rev. 2013. PMID: 23453861 Free PMC article. Review.

8

Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study.

Zaorsky NG, Malatesta TM, Showalter TN, Den RB, Shi W, Anne PR, Werner-Wasik M, Dicker AP, Bar-Ad V. Zaorsky NG, et al. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):214-5. doi: 10.1016/j.ijrobp.2013.02.001. Epub 2013 Mar 15. Int J Radiat Oncol Biol Phys. 2013. PMID: 23498775 No abstract available.

9

Multimodality therapy for patients with high-risk prostate cancer: current status and future directions.

Zaorsky NG, Trabulsi EJ, Lin J, Den RB. Zaorsky NG, et al. Semin Oncol. 2013 Jun;40(3):308-21. doi: 10.1053/j.seminoncol.2013.04.006. Semin Oncol. 2013. PMID: 23806496 Review.

10

The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?

Zaorsky NG, Raj GV, Trabulsi EJ, Lin J, Den RB. Zaorsky NG, et al. Semin Oncol. 2013 Jun;40(3):322-36. doi: 10.1053/j.seminoncol.2013.04.011. Semin Oncol. 2013. PMID: 23806497 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters